Successful glucocorticoid treatment for patients with abnormal autoimmunity on in vitro fertilization and embryo transfer

Purpose: To analyze the effects of glucocorticoid treatment for patients with abnormal autoimmunity on IVF-ET outcomes, low-dose predonisolone or dexamethasone was administered in 51 IVF-ET cycles of 41 patients with positive antinuclear antibody (ANA), anti-DNA antibody, and/or lupus anticoagulant (LAC). Rates of clinical pregnancy and implantation in these patients were compared with those in 48 cycles without corticosteroid therapy. Autoantibody-negative patients were also treated with IVF-ET combined with (29 cycles) or without (57 cycles) glucocorticoid administration, and the pregnancy and implantation rates were investigated.

Without glucocorticoid treatment, the pregnancy rate per cycle and implantation rate per embryo in antibody-positive patients were 10.4 and 3.8%, respectively. Significant increases in pregnancy (35.3%) and implantation (13.2%) rates were observed with corticosteroid treatment. In antibody-negative patients, the rates of pregnancy and implantation showed no significant differences with versus without the glucocorticoid administration.

Our results indicate that because autoimmune abnormalities may be at least one cause of implantation failure following IVF-ET, the combined use of low-dose corticosteroid can be effective for autoantibody-positive women. Similar content being viewed by others

Lubbe WF, Bulter WS, Palmer SJ, Ligginns GC: Lupus anticoagulant in pregnancy. Br J Obstet Gynecol 1984;91:357–363 Lockwood CJ, Reece EA, Romero R, Hobbins JC: Antiphospholipid antibody and pregnancy wastage. Lancet 1986;2:742–743 Gleicher N, El-Roeiy A: The reproductive autoimmune failure syndrome. Am J Obstet Gynecol 1988;159:223–227 Tabibzadeh S: Cytokines and the hypothalamic-pituitary-ovarian-endometrial axis. Hum Reprod 1994;9:947–967 Nakamura K, Osawa M, Kondo I, Inagaki S, Shibata H, Narita O, Suganuma N, Tomoda Y: Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilization in patients with endometriosis. J Assist Reprod Genet 1992;9:113–117 Fukugaki H, Suganuma N, Kitagawa T, Yamamoto M, Hibi H, Miyake K, Tomoda Y: Successful in vitro fertilization and pregnancy by the micromanipulation with epididymal sperm. J Assist Reprod Genet 1994;11:452–458 Suganuma N, Tsukahara S, Kitagawa T, Furuhashi M, Asada Y, Kondo I: A Controlled ovarian hyperstimulation regimen involving intermittent gonadotropin administration with a “short” protocol of gonadotropin releasing hormone agonist for in vitro fertilization. J Assist Reprod Genet 1996;13:43–48 Gleicher N, El-Roeiy A, Confino E, Friberg J: Is endometriosis an autoimmune disease? Obstet Gynecol 1987;70:115–122 Gleicher N: The role of humoral immunity in endometriosis. Acta Obstet Gynecol Scand 1994;159:15–17 Taylor PV, Maloney MD, Campbell JM, Skerrow SM, Nip MMC, Parmar R, Tate G: Autoreactivity in women with endometriosis. Br J Obstet Gynaecol 1991;98:680–684 Gleicher N, El-Roeiy A, Confino E, Friberg J: Reproductive failure because of autoantibodies; Unexplained infertility and pregnancy wastage. Am J Obstet Gynecol 1989;160:1376–1385 Taylor PV, Campbell JM, Scott JS: Presence of autoantibodies in women with unexplained infertility. Am J Obstet Gynecol 1989;161:377–379 Dmowski WP, Friberg J, Rana N, Papierniak C, Michalowska J, El-Roeiy A: The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates. Fertil Steril 1995;63:555–562 Geva E, Amit A, Lerner-Geva L, Azem F, Yovel I, Lessing JB: Autoimmune disorders: Another possible cause for in-vitro fertilization and embryo transfer failure. Hum Reprod 1995;10:2560–2563 Geva E, Vardinon N, Yaron Y, Burke M, Lessing JB, Amit A, Yovel I: Circulating autoimmune antibodies may be responsible for implantation failure in in vitro fertilization. Fertil Steril 1995;38:802–806 El-Roeiy A, Harlow L, Dmowski WP, Binor Z, Gleicher N, Tummon I, Radwanska E, Rawlins RG: Danazol but not gonadotropin-releasing hormone agonists suppresses autoantibodies in endometriosis. Fertil Steril 1988;50:864–871 Sher G, Feinman M, Zouves C, Kuttner G, Maassarani G, Salem R, Matzner W, Ching W, Chong P: High fecundity rates following in vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod 1994;9:2272–2283 Coulam CB, Krysa LW, Bustillo M: Intravenous immunoglobulin for in-vitro fertilization failure. Hum Reprod 1994;9:2265–2269 Cohen J, Kort H, Malter H, Massey J, Elsner C, Mayer MP: Immunosuppression supports implantation of zona pellucida dissected human embryos. Fertil Steril 1990;53:662–665 Polak de Friend E, Blanco L, Lancuba S, Asch RH: Improvement of clinical pregnancy rate and implantation rate of in-vitro fertilization-embryo transfer patients by using methylprednisone. Hum Reprod 1993;8:393–395 Moffitt D, Schoolcraft W, Queenan JT, Miller CE, Veeck LL, Muasher SJ: Low-dose glucocorticoids after in vitro fertilization and embryo transfer have no significant effect on pregnancy rate. Fertil Steril 1995;63:571–577 Lee K-A, Koo JJ, Yoon T-K, Do BR, Ko J-J Cha K-Y: Immunosuppression by corticosteroid has no effect on the pregnancy rate in routine in-vitro fertilization/embryo transfer patients. Hum Reprod 1994;9:1832–1835 El-Roeiy A, Gleicher N, Confino E, Friberg J, Dudkiewicz AB: Correlation between peripheral blood and follicular fluid: autoantibodies and impact on in vitro fertilization. Obstet Gynecol 1987;70:163–170 Nip MMC, Taylor PV, Rutherford AJ, Hancock KW: Autoantibodies and antisperm antibodies in sera and follicular fluids of infertile patients; Relation to reproductive outcome after in-vitro fertilization. Hum Reprod 1995;10:2564–2569 Bronson: Immunology and reproductive medicine. Hum Reprod 1995;10:755–757 Author information Authors and Affiliations Rights and permissions About this article Cite this article Ando, T., Suganuma, N., Furuhashi, M. et al. Successful glucocorticoid treatment for patients with abnormal autoimmunity on in vitro fertilization and embryo transfer. J Assist Reprod Genet 13, 776–781 (1996). https://doi.org/10.1007/BF02066497 Received: Accepted: Issue date: DOI: https://doi.org/10.1007/BF02066497